Covidh Technologies Ltd - 534920 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Covidh Technologies shareholders have approved seven key resolutions through postal ballot. These include increasing authorized share capital, revising MOA/AOA, enhancing investment limits, and acquiring Isera Biological Limited via a share swap.
May 22 2026 18:05:00
Covidh Technologies Ltd - 534920 - We Hereby Submit The Declaration W.R.T. Non Applicability Of Regulation 23(9) Of SEBI LODR
Covidh Technologies stated that certain SEBI (LODR) Regulations regarding corporate governance provisions, including related party transactions (Regulation 23(9)), do not apply to the company. This is due to its paid-up equity share capital being less than Rs.10 crore and net worth less than Rs.25 crore as of March 31, 2026.
May 21 2026 20:05:00
Covidh Technologies Ltd - 534920 - Board Meeting Outcome for Revised Outcome Of The Board Meeting
Covidh Technologies announced its audited FY26 annual results, with revenue soaring 411% YoY to Rs.1.35 crore and net profit increasing 120% to Rs.0.26 crore. Despite strong operational growth, EPS declined to Rs.0.74 from Rs.3.65 due to a significant increase in outstanding shares following a rights issue.
May 21 2026 20:05:00
Covidh Technologies Ltd - 534920 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 21St May, 2026 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Covidh Technologies reported FY26 total income of ₹1.42 crores and a net profit of ₹0.26 crores, marking growth from FY25. The company also completed a ₹8.08 crore rights issue of 80.85 lakh shares at ₹10 each during the fiscal year.
May 21 2026 19:05:00
Covidh Technologies Ltd - 534920 - Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited)Has Filed With Exchange Monitoring Agency Report For Quarter Ended March 31, 2026.
iSERA Lifesciences reported that Rs. 7.41 crore (91.7%) of its Rs. 8.08 crore Rights Issue proceeds remain unutilized for the quarter ended March 31, 2026. The Board has approved an extended timeline until September 30, 2026, citing strategic re-alignment and administrative lead times.
May 15 2026 22:05:00
Covidh Technologies Ltd - 534920 - Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Quarter Ended 31, March 2026.
iSera Lifesciences filed its Q4 FY26 monitoring report on rights issue proceeds, indicating Rs. 7.41 crore (out of Rs. 8.08 crore) remains unutilized. The board has approved an extension for fund deployment until September 30, 2026, due to strategic business realignment.
May 15 2026 22:05:00
Covidh Technologies Ltd - 534920 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Thursday, May 21, 2026 To Consider, Approve And Take On Record The Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026
Covidh Technologies' board is scheduled to meet on May 21, 2026, to consider and approve the standalone audited financial results for the quarter and year ended March 31, 2026.
May 15 2026 12:05:00
Read More
